Drug intelligence / Profile preview

LiteVax UPEC vaccine

Development stage: Preclinical
Lead developer: LiteVax
Modality: Vaccines & Immunotherapeutics

Overview

LiteVax UPEC vaccine is a prophylactic vaccine candidate designed to prevent urinary tract infections (UTIs) caused by uropathogenic *Escherichia coli* (UPEC). Developed by LiteVax, the vaccine utilizes the company's proprietary CMS (Carbohydrate-based Multi-component System) adjuvant technology to enhance the immune response against UPEC antigens. The project, known as UTOPIA and supported by the EUROSTARS program, is currently in the preclinical stage of development. The vaccine aims to provide a preventative solution for recurrent UTIs, potentially reducing the reliance on antibiotic treatments and addressing the growing concern of antimicrobial resistance in uropathogens.

Other names: LiteVax-Uropathogenic Escherichia coli (UPEC)-adjuvanted vaccine-prophylactic vaccine-Urinary tract infection (E. coli)UTOPIA (EUROSTARS)

Targets

FimH (Type 1 fimbrial adhesin)

Beyond the preview

Go deeper on LiteVax UPEC vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LiteVax UPEC vaccine.

Explore the full profile